Introduction
Quinolones have been found to possess an antibiotic property. Fluorinated 4-quinolone derivatives have a broad-spectrum antibacterial activity against many gram-positive and gramnegative bacteria through inhibition of their DNA gyrase. [1] [2] [3] Lomefloxacin (LFX) [1-ethyl-6,8 -difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid], Separefloxacin (SFX) [rel-5-amino-1-cyclopropyl-7-{(3R, 5S),3,5-dimethyl-piperazinyl}-6,8-difluoro-1,4-dihydro-4-oxo-3-quinholinecarboxylic acid], and Gatifloxacin (GFX) [1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid] are new additions to the class of fluoroquinolones that are widely used in the treating of respiratory trace and urinary trace infections. 4 The structures of the cited drugs are shown in Table 1 .
Lomefloxacin is rapidly and almost completely absorbed following oral administration. The elimination halflife of Lomefloxacin is about 7 to 8 h. Lomefloxacin is extracted in the urine, mainly as an unchanged drug. 5 Sparfloxacin has been reported to be more active in vitro than other quinolones against some microorganisms, including staphylococci and mycobacteria, 6, 7 and has a 16 h plasma halflife. 8 Gatifloxacin is an advanced-generation fluoroquinolones that offers several advantages over previous agents, including enhanced in vitro activity against clinically important pathogens and improved pharmacokinetics.
These advantages result in enhanced pharmacodynamics, which may improve patient outcomes against certain bacterial pathogens, especially penicillinresistant streptococcus pneumonia. 9 The mechanism of action of fluoroquinolones antibacterial involves the inhabitation of bacterial topoisomerase IV and DNA gyrase (both of which are type-II topoisomerases, enzymes required for DNA replication, transport, repair and recombination). 10 Two exhaustive reviews 11, 12 are available that describe the current status of the analytical techniques for fluoroquinolones antibiotics. Few methods have been reported for the determination of LFX, SFX and GFX either pure or in dosage forms. For GFX, only three published papers 9,13,14 have described the complete methodology for a validation assay procedure, but no electrochemical method has been published for its determination. For SFX spectrophotometry, HPLC 15, 16 and polarographic methods have been reported. 17 For LFX methods using various techniques have been reported including spectrophotometry, 18 HPLC 19 and polarography. 20 The most sensitive electrochemical procedures for the demonstration of the trace concentrations of various pharmaceutical compounds have conventionally employed a two-step approach consisting of: (i) An initial preconcentration step, during which the analyte is allowed to accumulate at the electrode surface under carefully controlled conditions. (ii) A subsequent measurement in which the accumulated analyte is then stripped-off and determined by a voltammetric method. This preconcentration/measurement sequence forms the basis of all of the so-called stripping techniques that permit the determination of electroactive compounds at very low concentration. 21 The application of microelectrodes to different analytical and kinetic studies offers several advantages compared to regular area electrodes. [22] [23] [24] [25] [26] They enhanced the mass transport and reduce the apparent electrochemical reversibility, allowing the determination of higher rate constants than regular-area electrodes. 26 Cyclic voltammetry and differential pulse voltammetry were used to explore the adsorption behavior of three antibacterial agents at a carbon paste electrode. The drugs were accumulated on a carbon paste electrode, and a well-defined oxidation peak was obtained in acetate buffer (pH 5.0). The adsorptive stripping response was evaluated as a function of some variables such as the scan rate, pH and accumulation time. A simple, precise, inexpensive and sensitive voltammetric method has been developed for the determination of the cited drugs (Lomefloxacin (LFX), Sparfloxacin hydrochloride (SFX), and Gatifloxacin (GFX)). A linear calibration was obtained from 2 × 10 -7 M to 4 × 10 -5 M for LFX, 2 × 10 -7 M to 6 × 10 -5 M for SFX, and GFX. The limits of detection (LOD) were 4.2 × 10 -7 , 7 × 10 -7 and 6.6 × 10 -7 M, while the limits of quantification (LOQ) were 1.4 × 10 -6 , 2.3 × 10 -6 and 2.2 × 10 -6 M for LFX, SFX, and GFX, respectively. The R. S. D. of five measurements at the 1 × 10 -6 M level were 0.4, 0.5 and 0.3 for LFX, SFX and GFX, respectively. The method was applied to the determination of LFX, SFX and GFX in dilute urine samples and dosage forms, and compared with the HPLC method.
rates and analysis in vivo and in micro samples can be considered as some of the most important uses of micro electrodes. [22] [23] [24] Carbon-paste electrodes are convenient, and are often used as working electrodes for voltammetric and amperometric measurements because of their attractive properties. [28] [29] [30] From an analytical point of view, these electrodes exhibits rather low background currents over a large range of potentials when compared with other solid electrodes, and after a renewability of their surface as well as a high versatility and simplicity of modification.
A literature survey revealed that no attempt has been made to study the voltammetric behavior of LFX, SFX and GFX as an oxidation process. However, the polarographic and adsorptive behaviors at hanging mercury electrode of different fluoroquinolones have been reported. 17, 20, [31] [32] [33] [34] [35] [36] [37] The present work demonstrates that LFX, SFX and GFX could be adsorbed on a carbon paste electrode. Concerning this feature, an adsorptive cyclic anodic stripping voltammetric method for the analysis of LFX, SFX and GFX has not been developed. A method has been applied for the direct determination of these three drugs in diluted urine samples.
Experimental

Apparatus
Voltammetric measurements were carried out using a computer-driven AEW2 analytical electrochemical workstation with ECProg3. Electrochemistry software (Sycopel, England) in combination with a C-2 stand with a three-electrode configuration; a carbon paste electrode (BAS Model MF-2010, 3 mm diameter) working electrode, An Ag/AgCl/3 M KCl (BAS Model MF-2063) reference electrode and a platinum wire (BAS Model MW-1032) counter electrode. Microcal Orgin (Ver.5) software was used to transform the initial signal. A Mettler balance (Toledo-AB104) was used for weighing the solid materials.
A Cyberscan 500 digital (EUTECH Instruments, USA) pH-meter with a glass combination electrode served to carry out pH measurements.
A micropipette (Eppendorf-multipette ® Plus) was used throughout the present experimental work.
De-ionized water used throughout the present study was supplied from a Hamilton-Aqua-Matic bi-distillation water system.
Reagents
Alkan Pharma, Ema Pharm and Bristol Myers Squibb companies kindly provided, LFX, SFX, and GFX, respectively, and their pharmaceutical dosage forms (Lomeflox, Sparcin and Tequin, respectively), Egypt.
A stock solution of LFX, SFX and GFX 1 × 10 -3 M was prepared with water and stored in a dark bottle at 4˚C. Diluted working standard solutions were then prepared daily from the stock solution with de-ionized water.
Unless otherwise stated, acetate buffer solutions (0.05 M, pH 5.0) were used as supporting electrolytes. The working solution under voltammetric investigations was prepared by dilution of the stock solution with a selected supporting electrolyte. All solutions were prepared from Analar-grade reagents (Merck and Sigma) in doubly distilled water.
The paste was prepared by thoroughly hand mixing 0.5 g of graphite powder (Measurements Ringsdorff Werker, Germany) with 0.2 ml of paraffin oil (Merck) in an agate mortar with pestle. The electrode surface of CPE (2 mm in diameter) was polished mechanically by smoothing some paste off with wet filter paper. The differential pulse voltammetry conditions were: pulse amplitude, 50 mV; pulse width, 50 ms; step potential, 4 mV; scan rate, 10 mV s -1 , between +0.2 and +1.2 V.
General analytical procedure
A 5-ml volume of acetate buffer was introduced into a microelectrolyte cell. The accumulation (usually open-circuit condition) of LFX, SFX and GFX at the working electrode was carried out for a certain time while the solution was being stirred at 2000 rpm. The stirrer was then stopped, and after a 5-s rest period the drug was removed by stripping anodically using differential pulse voltammetry DPV, (pulse amplitude, 50 mV; pulse width, 50 ms; scan rate, 10 mV s -1 ). Voltammograms were recorded, aliquots of the drug standard were introduced and the adsorptive stripping cycle was repeated using a new electrode surface. The peak current was evaluated as the difference between each voltammogram and the background electrolyte voltammogram. All data were obtained To study the reproducibility, accuracy and precision of the proposed procedure to determine the drug in bulk form, tablets and human urine sample recovery experiments were carried, by means of both the calibration curve and standard addition.
Tablets solution
Ten tablets of (Lomeflox, Sparcin and Tequin) that contained a declared amount of 400, 200 and 400 mg of LFX, SFX and GFX, respectively, were crushed and powdered in a morter. A weighed portion of the powder equivalent to 1 × 10 -3 M of LFX, SFX and GFX was treated with water for 10 min in an ultrasonic bath. Appropriate solutions were prepared by taking suitable aliquots of the clear supernatant liquer and diluting with the selected supporting electrolyte to a 10 ml volume calibrated flask. The solution was directly analyzed, according to the general analytical procedure without the necessity for sample pretreatment or any extraction steps.
Procedure for urine assay
For the determination of LFX, SFX and GFX in spiked urine samples, the preconcentration/voltammetry scheme was adopted. Urine (1 ml) was mixed with 9.0 ml of acetate buffer, pH 5.0, without any pretreatment and transferred to the voltammetric cell. The cyclic voltammograms were recorded following optimized conditions: accumulation time, tacc = 30 s, at open circuit; quantification was achieved by the standard addition method.
Results and Discussion
Anodic cyclic voltamograms for the oxidation of Lomefloxacin (LFX), Sparefloxacin (SFX), and Gatifloxacin (GFX) in acetate buffer pH 5 at carbon paste electrode are shown in Fig. 1 . Cyclic voltamograms of 5 × 10 -5 M in acetate buffer (0.05 M, pH 5.0) on a carbon paste electrode following 30 s of stirring. Definite anodic peaks, corresponding to oxidation of the adsorbed drug, were observed at +0.87, +0.89 and +0.67 V for LFX, SFX and GFX. In a forward scan, a single anodic peak was observed with no cathodic peak in the reverse sweep, which indicates that Lomefloxacin, Sparefloxacin and Gatifloxacin oxidation is irreversible. The anodic peak may be attributed to the irreversible oxidation of the piperazine moiety of the LFX, SFX, and GFX molecules. 38 The influence of the scan rate on the peak current (ip) was studied Fig. 2 within the range 10 -300 mV s -1 for LFX and GFX and 25 -300 mV s -1 for SFX. The peak potential moves to a more positive potential with increasing the scan rate, which confirms the irreversibility of the process. The linear increase in the oxidation peak current with the scan rate shows the adsorption control process. A plot of the peak current versus scan rate for LFX, SFX, and GFX gave a straight line which fitted the equation ip (µA) = (0.40165 ± 0.0403) + (0.0066 ± 2.502 × 10 39 respectively. In this study, 10 mV s -1 was chosen for the scan rate, because at this value the sensitivity was relatively high and the voltammetric curves were well-shaped with a relatively narrow peak width.
The influence of the pH and the type of supporting electrolyte on the peak current for each drug was examined in a Briton-Robinson buffer using cyclic voltammetry (Fig. 3) . The composition of the supporting electrolyte was evaluated for 5 × 10 range 0.04 -0.2 M. Fluoroquinoline possesses two ionizable groups: a carboxylic group and basic piperanyzyl group. 10, 40 Depending on the given pH and considering the electrostatic attachment, one could expect that the cationic form exits at pH 5.0. It was found that, the maximum size peaks were obtained with 0.05 M acetate buffer (pH 5.0) [peak current in acetate buffer > peak current in Briton-Robinson buffer (pH 5.0)], which was used as a favorable buffer throughout this study.
The dependence of the peak current developed in the buffer solution (pH 5.0) on the accumulation time was investigated for three compounds: (a) LFX, (b) SFX and (c) GFX, as shown in Fig. 4 at concentration levels 1 × 10 -5 M. Figure 4 shows the plot of ip vs. tacc for 1 × 10 -5 M solution. A full surface coverage was established after an accumulation time of tacc = 30 s, for the three compounds LFX, SFX and GFX. Thus, the accumulation time of choice is dictated by the sensitivity.
The effect of the accumulation potential as a function of the peak current was also evaluated over the range +0.2 to +1.2 V. The peak stripping current was independent on accumulation potential; thus the adsorption stage was carried out at an opencircuit potential.
A difference in the value of the peak current observed in Figs. 3 and 4 may be due to the difference in the structure of these drugs under investigation, which affects the value of the oxidation peak.
Analytical application
Validation of the analytical procedure. The validation of the proposed procedure for the quantitative assay of LFX, SFX, and GFX was examined via an evaluation of the LOD, LOQ, repeatability, recovery, selectivity, and robustness. Calibration curves within the concentration levels of drugs were attempted following an accumulation period of 30 s. The regression equations associated with the calibration plots exhibited good linearity (Table 2) , which supported the validation of the proposed procedure for quantifying the drugs. The standard deviations of the calibration curves were 0.0064, 0.0060, and 0.0067, and the limits of detection were 4.2 × 10 -7 , 7 × 10 -7 and 6.6 × 10 -7 M for LFX, SFX, and GFX, respectively. The precision of this method was determined by successive measurements of five solutions of 1 × 10 -6 M LFX, SFX, and GFX. The RSD was 0.4, 0.5, and 0.3%, respectively. Spiked urine samples. The applicability of the cyclic anodic stripping voltammetry to the determination of LFX, SFX and GFX in urine was investigated. Figure 5 illustrates the differential pulse voltammetric response to different concentrations of LFX, SFX and GFX in urine samples mixed with 9.0 ml acetate buffer (pH 5.0) after 30 s of accumulation under open-circuit conditions. The peak current was linearly related from 1 -10, 2 -12, and 2 -18 µg ml -1 of LFX, SFX, and GFX, respectively, in urine (i.e. 2 × 10 -4 to 2 × 10 -3 µg ml -1 , 4 × 10 -4 to 2.4 × 10 -3 µg ml -1 and 4 × 10 -4 to 3.6 × 10 -3 µg ml -1 in voltammetric measurements cell for LFX, SFX, and GFX, respectively).
The standard deviation for the slope of the calibration was 0.0172, 0.00384 and 0.01073%; the detection limits were 1.5, 0.4 and 1.1 µg ml -1 for LFX, SFX, and GFX, respectively, in urine (Table 3) .
Interference.
For possible analytical applications of the proposed method, the effect of some common excipients used in pharmaceutical preparations were studied by analyzing sample solutions containing a fixed amount of drug spiked with various excess amounts under the same experimental conditions. Some tested excipients, such as glucose and lactose, were used.
The determination of 1 × 10 -6 M LFX, SFX, and GFX in the presence of the above maintained excipients was evaluated, and 1252 ANALYTICAL SCIENCES OCTOBER 2005, VOL. 21 Table  4 indicate that there is no significant difference between the proposed and HPLC method with respect to the precision and accuracy. The repeatability of the method was determined from multiple measurements at each of the studied samples (n = 5). The analysis of LFX, SFX, and GFX in spiked human urine samples exhibited the correlation coefficients of 0.9971, 0.9996, and 0.9980, respectively, and standard deviations of 0.0172, 0.0038, and 0.0107, respectively, indicating adequate precision and accuracy of the proposed method.
In conclusion, the voltametric method proposed in this work for the quantitation of the cited drugs is a direct method, and more sensitive than other reported methods. 13, 20 Furthermore, the proposed method is simple, accurate, precise and does not need the elaborated treatment and tedious extractions required in chromatographic methods. The proposed method was used to determine LFX, SFX, and GFX in raw materials and human urine at the level found after drug administration at normal doses. The main advantages of the method are rapidity, no pretreatment, low cost, simplicity and non-destructive nature. Moreover, because of its very low limits of detection and quantitation, the proposed procedure could be applied in clinical laboratories. ANALYTICAL SCIENCES OCTOBER 2005, VOL. 21
Parameter LFX SFX GFX Table 3 Validation data for the determination of LFX, SFX, and GFX in spiked urine 
